LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market.
The Voke Inhaler contains no electronics, heat or combustion and is designed to rival both e-cigarettes and nicotine-replacement therapies, such as gum and patches.
The product was developed by Kind Consumer, working with Consort Medical, and the next step will be to submit a variation to the licence granted by the Medicines and Healthcare products Regulatory Agency (MHRA) to support full-scale commercialisation by BAT's Nicoventures, the companies said. (Reporting by Ben Hirschler, Editing by Paul Sandle)
FIND OUT MORE ABOUT 'BEN Latest News'
'Like us on Facebook'
http://www.facebook.com/pages/BEN-Latest-News/443681719077160
'Follow us on Twitter'
www.twitter.com/benlatestnews
For Advertisment and Partnering with us contact CEO on BB PIN: 260158B5
BEN Latest News™
The Voke Inhaler contains no electronics, heat or combustion and is designed to rival both e-cigarettes and nicotine-replacement therapies, such as gum and patches.
The product was developed by Kind Consumer, working with Consort Medical, and the next step will be to submit a variation to the licence granted by the Medicines and Healthcare products Regulatory Agency (MHRA) to support full-scale commercialisation by BAT's Nicoventures, the companies said. (Reporting by Ben Hirschler, Editing by Paul Sandle)
FIND OUT MORE ABOUT 'BEN Latest News'
'Like us on Facebook'
http://www.facebook.com/pages/BEN-Latest-News/443681719077160
'Follow us on Twitter'
www.twitter.com/benlatestnews
For Advertisment and Partnering with us contact CEO on BB PIN: 260158B5
BEN Latest News™
No comments:
Post a Comment